The funding will be funnelled into an unnamed p53 suppressor-focused oncology Weizmann spinout and ultrasound guidance device maker On-Sight Medical.

KU Leuven has generated 60 spinouts since 2000, the most of any Flemish region university, while digital-focused research centre IMinds topped the bill for Flemish strategic institutes.

Based on Stanford research, Surrozen is working on regenerative treatments for a wide range of conditions, with a first focus on liver disease.

Sherlock Biosciences will develop molecular diagnostics tools co-developed by researchers at Harvard University and Broad Institute, including Crispr inventor Feng Zhang.

University of Dundee intelligent drug design spinout Exscientia has struck a business deal with Celgene after raising series B funding from the corporate in January.

OSF Ventures, OSF Healthcare's corporate venturing unit, has backed healthcare-focused VC firm LRVHealth's fourth fund, which had set a $100m target for close.

Eric Steager, formerly managing director at Independence Blue Cross’ Strategic Innovation Portfolio unit, has taken a vice-president of corporate venture capital position at Anthem.

Smith & Nephew and Johnson & Johnson have exited the shoulder implant developer in an all-cash acquisition by Stryker that could reach $220m.

TAU-founded Qart Medical has been backed by the university’s Technology Innovation Momentum Fund and Chartered Investment Managers, itself a partner in TAU Ventures.

Embattled commercialisation firm NetScientific is closing two medical diagnostics spinouts from UCLA after both failed to attract external funding.